In contrast, proportions of Annexin V+CD95+CD3+ T cells were less stable in patients with breast cancer, as two out of four patients for whom two serial tests were available had a decreased and the other two increased proportions of these cells on repeated examination. The gene discussed is ANXA5; the disease is breast carcinoma.